Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT04090307
Other study ID # 201901030
Secondary ID
Status Enrolling by invitation
Phase N/A
First received
Last updated
Start date November 26, 2019
Est. completion date December 2024

Study information

Verified date May 2024
Source Washington University School of Medicine
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To conduct a randomized trial to determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on maternal and neonatal outcomes in women at high risk for developing gestational diabetes mellitus (GDM).


Description:

Long term, the investigator aims to test the central hypothesis that those in TLC will have better maternal and neonatal outcomes than those in TC. The objective is to conduct a randomized trial to determine the effect of TLC group prenatal care on birthweight and neonatal body composition, maternal healthy lifestyle and diabetes-related outcomes, delivery and neonatal outcomes, and psychosocial stress and depression.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 416
Est. completion date December 2024
Est. primary completion date June 2024
Accepts healthy volunteers No
Gender Female
Age group 13 Years and older
Eligibility Inclusion Criteria: - English speaking - =16 weeks' gestation - Two or more of the following GDM risk factors: - BMI=25 - Physical inactivity - First degree relative with diabetes - High risk race or ethnicity (African American, Latino, Native American, Asian American, Pacific Islander) - Prior infant weighing = 4,000 g - Prior GDM - Hypertension (140/90 mm Hg or receiving treatment) - High-density lipoprotein cholesterol level <35 mg/dL or triglycerides > 250 mg/dL - Polycystic ovarian syndrome - A1c=5.7% - Impaired glucose tolerance - Impaired fasting glucose on previous testing - History of cardiovascular disease - Ability to attend group prenatal visits at specified days and times - Willingness to be randomized - Ability to give informed consent Exclusion Criteria: - Type 2 diabetes (eligible for Diabetes Group Care) - Positive glucose challenge test during early pregnancy - Multiple gestation (require extra care) - Major fetal anomaly (require extra care) - Serious medical co-morbidity necessitating more care than can be safely provided in group setting, as deemed by medical provider (require extra care) - Serious psychiatric illness, including schizophrenia, necessitating more care than can be safely provided in group setting, as deemed by medical provider (require extra care)

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
TLC Group Prenatal Care
TLC will start in the late first trimester or early second trimester and run for ~6-10 sessions. Groups of 2-10 consented women, with two or more GDM risk factors, will meet under the supervision of an obstetric provider (nurse practitioner or MD) and co-facilitator (health educator, nutritionist, or nurse) for two-hour sessions. A major focus of TLC will be education, and much of each visit will be spent on pregnancy, exercise/nutrition education, and behavioral health.

Locations

Country Name City State
United States Washington University in St. Louis Saint Louis Missouri

Sponsors (1)

Lead Sponsor Collaborator
Washington University School of Medicine

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Effects of TLC group prenatal care on birth weight Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on infant weight in grams Delivery/within 1 week of delivery
Primary Effects of TLC group prenatal care on neonatal length Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on infant length in cm Delivery/within 1 week of delivery
Primary Effects on TLC group prenatal care on neonatal head circumference Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on infant head circumference in cm Delivery/within 1 week of delivery
Primary Effects of TLC group prenatal care on infant skinfold thickness Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on infant skinfold thickness of ilium, thigh, triceps, and subscapular Delivery/within 1 week of delivery
Secondary Maternal diagnosis of gestational diabetes Assessing maternal diagnosis of gestational diabetes using 2-step method(1-hour glucose challenge test, 3-hour glucose tolerance test, need for medication) Up to the time of delivery
Secondary Physical activity and eating behavior Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on physical activity and eating behavior survey At enrollment, the last study visit/delivery, and 4-12 weeks postpartum
Secondary Maternal gestational weight gain Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on maternal gestational weight gain Initial visit through 4-12 weeks postpartum
Secondary Maternal hypertensive disorders of pregnancy including gestational hypertension, chronic hypertension, preeclampsia, eclampsia, and HELLP Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on maternal hypertensive disorders of pregnancy Initial visit through 4-12 weeks postpartum
Secondary Rates of appointment attendance Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on number of prenatal visits attended Up to the time of delivery
Secondary Rates of maternal postpartum visit attendance for those in TLC compared to traditional prenatal care Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on postpartum visit attendance 4-12 weeks postpartum
Secondary Rate of maternal contraception initiation for those in TLC compared to traditional prenatal care. Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on maternal postpartum contraception initiation Delivery through 4-12 weeks postpartum
Secondary Breastfeeding rates among those in TLC compared to traditional prenatal care. Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on maternal breastfeeding Delivery through 4-12 weeks postpartum
Secondary Postpartum weight retention Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on maternal postpartum weight retention Up to 12 weeks postpartum
Secondary Postpartum 2 hour glucose tolerance testing (if applicable) Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on maternal glucose tolerance testing 4-12 weeks Postpartum
Secondary Insulin resistance Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on maternal insulin resistance (fasting and 30 min insulin). Through study completion, up to 12 weeks postpartum
Secondary Insulin sensitivity Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on maternal insulin sensitivity (fasting and 30 min insulin). Through study completion, up to 12 weeks postpartum
Secondary Assessing prenatal care patient satisfaction for those in TLC compared to traditional prenatal care using a satisfaction survey. Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on maternal prenatal care satisfaction Delivery
Secondary Neonatal gestational age at delivery Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on infant gestational age at delivery Delivery
Secondary Induction of labor rates for those in TLC compared to traditional prenatal care Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on maternal induction of labor Delivery
Secondary Mode of delivery for those in TLC compared to traditional prenatal care. Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC)on maternal mode of delivery Delivery
Secondary Neonatal shoulder dystocia rates for those in TLC compared to traditional prenatal care. Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on infant shoulder dystocia Delivery
Secondary Neonatal APGAR score Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on infant APGAR score Delivery
Secondary Neonatal cord blood analytes Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on infant cord blood analytes, c-peptide. Delivery
Secondary Neonatal cord blood analytes of pH for those in TLC compared to traditional prenatal care. Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on infant cord blood analytes, pH. Delivery
Secondary Neonatal cord blood analytes of base excess for those in TLC compared to traditional prenatal care. Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on infant cord blood analytes, base excess. Delivery
Secondary Neonatal NICU admission Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on infant NICU admission Delivery
Secondary Neonatal hypoglycemia Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on infant hypoglycemia Delivery
Secondary Neonatal hematocrit Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on infant hematocrit Delivery
Secondary Neonatal jaundice Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on infant jaundice Delivery
Secondary Neonatal respiratory distress syndrome Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on infant respiratory distress syndrome Delivery
Secondary Neonatal stillbirth Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on infant stillbirth Delivery
Secondary Depression Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on maternal depression using Edinburgh Postnatal Depression Scale Enrollment through 4-12 weeks postpartum
Secondary Psychosocial stress Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on maternal stress using the perceived stress scale Enrollment through 4-12 weeks postpartum
Secondary Determine the effect of TLC on psychosocial stress and depression using the pregnancy distress questionnaire Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on maternal distress Enrollment through 4-12 weeks postpartum
Secondary Determine the effect of TLC on psychosocial stress and depression using the life events checklist Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on maternal life events Enrollment through 4-12 weeks postpartum
Secondary Determine the effect of TLC on psychosocial stress and depression using the generalized anxiety disorder-7 test Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on maternal anxiety Enrollment through 4-12 weeks postpartum
Secondary Determine the effect of TLC on psychosocial stress and depression using the Munich Chronotype Questionnaire (MCTQ) Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on maternal sleep hygiene. Enrollment through 4-12 weeks postpartum
See also
  Status Clinical Trial Phase
Completed NCT03442582 - Afluria Pregnancy Registry
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Enrolling by invitation NCT05415371 - Persistent Poverty Counties Pregnant Women With Medicaid N/A
Completed NCT04548102 - Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman N/A
Completed NCT03218956 - Protein Requirement During Lactation N/A
Completed NCT02191605 - Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy N/A
Completed NCT02223637 - Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
Recruiting NCT06049953 - Maternal And Infant Antipsychotic Study
Completed NCT02577536 - PregSource: Crowdsourcing to Understand Pregnancy
Not yet recruiting NCT06336434 - CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy Phase 1/Phase 2
Not yet recruiting NCT04786587 - Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
Not yet recruiting NCT05412238 - Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months N/A
Not yet recruiting NCT05028387 - Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
Completed NCT02683005 - Study of Hepatitis C Treatment During Pregnancy Phase 1
Completed NCT02783170 - Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women Phase 4
Recruiting NCT02507180 - Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
Recruiting NCT02619188 - Nutritional Markers in Normal and Hyperemesis Pregnancies N/A
Recruiting NCT02564250 - Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women N/A
Completed NCT02408315 - Induction With Misoprostol: Oral Mucosa Versus Vaginal Epithelium (IMPROVE) Phase 3